New Delhi, January 23: Hyderabad-based Bharat Biotech’s intranasal heterologous booster dose is more likely to be obtainable out there within the first week of February […]
Hyderabad, December 28: Two main vaccine makers from Hyderabad, Organic E Ltd and Bharat Biotech, collectively are holding about 250 million doses of COVID-19 vaccines […]
New Delhi, November 25: The Drugs Controller General of India (DCGI) has given approval to intranasal “Five Arms” booster dose for restricted use for COVID-19 […]
New Delhi, November 17: The Government has rejected media reports which claim that regulatory approval for Covaxin was rushed due to “political pressure”. The reports […]
There have been media reports claiming that Bharat Biotech, manufacturer of the indigenous COVID-19 vaccine – Covaxin, “had to skip certain processes” and “speed” up […]
Bengaluru, July 15: The Karnataka government has prepared district-wise micro plans for conducting workplace vaccinations along with door-to-door inoculation drive to implement the 75-days COVID […]
New Delhi, July 8: The National Technical Advisory Group on Immunisation’s (NTAGI) Standing Technical Sub-Committee (STSC) has given a nod for the use of Biological […]
New Delhi, September 13: The World Health Organization’s approval for the indigenous COVID-19 vaccine Covaxin, developed by the Hyderabad-based Bharat Biotech, is likely to come […]
New Delhi, Sep 5: The Centre has shared a set of parameters with all states and UTs to enable service providers and monitoring teams under […]
New Delhi, August 15: To cover more people in the COVID-19 vaccination drive, the Delhi government on Sunday issued an order to reserve 70 per […]
Copyright © 2023 | Fresh Headline